Edwards Lifesciences Corporation

EW · Healthcare · · USD

89.90 USD

+0.00 (0.13%)

● Updated 2026-09-07 21:05 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score BUY Long-term (Investment)

/ 100

Technical 75

Trend & RS 70

Momentum 56

Fundamental 89

Macro 64

Liquidity 44

Component	Score	Weight
Technical	75.0	10%
Trend & RS	69.8	10%
Momentum	56.3	5%
Fundamental	88.9	40%
Macro	64.4	15%
Liquidity	44.4	20%

Trade Setup

Entry	89.90
Stop Loss	85.90 (4.5%)
Target 1 (1:1)	93.90 (+4.5%)
Target 2 (2:1)	97.90 (+8.9%)

ATR(14)	2.00 (2.2%)
Risk per Share	4.00
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	24.8	-1.01
Momentum	56.3	+0.25
Quality	63.1	+0.52
Composite	48.1

Quality Scores

Piotroski F-Score 7 /9 — Strong

✓ ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 46.91 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Overvalued

Metric	Stock	Sector	vs Peers
P/E Ratio	53.5	22.0	+143% above
P/B Ratio	4.9	4.0	Above

Comparing against Healthcare median multiples.

Trading at a premium to sector peers — verify growth justifies premium.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value

33.68

Market Price

89.90

Upside

-62.5%

Margin of Safety	-166.9%
Stage 1 PV (5yr FCF)	4,392,285,092
Terminal Value PV	15,020,794,923
Total Enterprise Value	19,413,080,015

Assumptions

Base FCF	774,681,600
Growth Rate (5yr)	13.6%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

46.58%

Full Kelly

23.29%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 71/100. Estimated win rate 61%, avg win 9.3%, avg loss 3.6%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

49.31

RSI(14)

0.3219

MACD

Relative Strength (RS) NEUTRAL

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (-0.1% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (43d since high)
Sector Outperformance	-3.2% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

NEUTRAL: In line with the market — no strong outperformance or underperformance.

Technical Indicators

Indicator	Value	Signal
Rsi	49.31	NEUTRAL
Macd	0.3219	BEARISH
Ma Cross	89.64 / 84.95	GOLDEN CROSS
Trend Short		ABOVE SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.94x	NORMAL

Key Levels

Level	Price
52-Week High	96.29
Bollinger Upper	93.32
SMA(200)	84.95
SMA(50)	89.64
SMA(20)	91.04
Current Price	89.90
Bollinger Lower	88.77
52-Week Low	72.30
ATR(14)	2.0

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION B Confidence

67%

Volume Dry-Up (Accumulation)

Acc: 2.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.44x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.91x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.93x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.66x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.94x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	90.68	Above Kijun
Kijun-sen (26)	89.57	Base line
Senkou A	90.12	Leading span A
Senkou B	88.72	Leading span B
Cloud	88.72 – 90.12	Bullish (Green)
Price vs Cloud	89.90	Inside Cloud
Chikou Span	86.07	Bullish
Alignment Score	3/4	NEUTRAL